Concepedia

Vishal Pendharkar

VP

Statistics

Publications

19

Citations

1.5K

H-Index

16

Active since

2012

Affiliations

Experimental Drug Development Centre(Current)

Agency for Science, Technology and Research

Duke-NUS Medical School

National University of Singapore

Nanyang Technological University

Vishal Pendharkar is an author at Experimental Drug Development Centre specializing in medicine, pharmacology, and cell biology.

Top concepts

Publications per year

2012–2021

19

Publications

19

Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer

Kyle David Proffitt, Babita Madan, Zhiyuan Ke et al. · Cancer Research · 2012 · 383 citations

Wnt addiction of genetically defined cancers reversed by PORCN inhibition

Babita Madan, Zhanbo Ke, Nathan Harmston et al. · Oncogene · 2015 · 339 citations · Full text

, , +16

Toward Resolving the Resveratrol Conundrum: Synthesis and <i>in Vivo</i> Pharmacokinetic Evaluation of BCP–Resveratrol

Yi Ling Goh, Yan Cui, Vishal Pendharkar et al. · ACS Medicinal Chemistry Letters · 2017 · 110 citations · Full text

p53 Maintains Genomic Stability by Preventing Interference between Transcription and Replication

Constance Qiao Xin Yeo, Irina Alexander, Zhaoru Lin et al. · Cell Reports · 2016 · 98 citations · Full text

Fragment-Based Ligand Design of Novel Potent Inhibitors of Tankyrases

Andreas Larsson, Anna Jansson, Fui Mee Ng et al. · Journal of Medicinal Chemistry · 2013 · 65 citations · Full text

, , +11

1–5 of 19